Key Metrics
CiteScore 

8.1
Impact Factor 

5 - 10
SNIP 

2.1
Recommended pre-submission checks
Powered by 

Topics Covered on JHEP Reports
JHEP Reports Journal Specifications
Indexed in the following public directories
Web of Science
DOAJ
SJR
| Overview | |
| Publisher | ELSEVIER |
| Language | English |
| Frequency | Bi-monthly |
| Article Processing Charges | EUR 2000 |
| Publication Time | 15 |
| Editorial Review Process | Anonymous peer review |
| General Details | |
| Language | English |
| Society/Institute/Sponsor | EASL: European Association for the Study of the Liver |
| Frequency | Bi-monthly |
| Publication Start Year | 2019 |
| Publisher URL | Visit website |
| Website URL | Visit website |
| Publication Details | |
| Editorial Review Detail | |
| Information for authors | |
| Author instructions | Visit website |
| Copyright Details | Visit website |
| License type | CC BY, CC BY-NC-ND |
| OA statement | Visit website |
View less
Planning to publish in JHEP Reports ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations

Recently Published Papers in JHEP Reports
Second-Line TKI after First-Line Immunotherapy-based Treatment in Advanced HCC: Reconstructed IPD Meta-analysis.
- 12 May 2026
- JHEP reports : innovation in hepatology
Quantitative magnetic resonance cholangiopancreatography metrics improve prognostication in primary sclerosing cholangitis.
- 12 May 2026
- JHEP reports : innovation in hepatology
Actin-specific smooth muscle antibodies in juvenile autoimmune liver diseases: Heterogenous diagnostic accuracy across varying test systems.
- 9 May 2026
- JHEP reports : innovation in hepatology
Comment on: Real-world quality of life and healthcare resource utilization in patients with metabolic dysfunction-associated steatohepatitis - Circular definition of CVRM comorbidities undermines the validity of core subgroup comparisons.
- 9 May 2026
- JHEP reports : innovation in hepatology
Epithelial MLCK deficiency alleviates alcohol-associated liver disease via dendritic-Th17 cell axis.
- 8 May 2026
- JHEP reports : innovation in hepatology
Targeting a tolerogenic HLA-G genotype to tackle immune evasion and adaptive resistance in HBV-driven HCC.
- 8 May 2026
- JHEP reports : innovation in hepatology
Second-Line TKI after First-Line Immunotherapy-based Treatment in Advanced HCC: Reconstructed IPD Meta-analysis.
- 12 May 2026
- JHEP reports : innovation in hepatology
Quantitative magnetic resonance cholangiopancreatography metrics improve prognostication in primary sclerosing cholangitis.
- 12 May 2026
- JHEP reports : innovation in hepatology
Actin-specific smooth muscle antibodies in juvenile autoimmune liver diseases: Heterogenous diagnostic accuracy across varying test systems.
- 9 May 2026
- JHEP reports : innovation in hepatology
Comment on: Real-world quality of life and healthcare resource utilization in patients with metabolic dysfunction-associated steatohepatitis - Circular definition of CVRM comorbidities undermines the validity of core subgroup comparisons.
- 9 May 2026
- JHEP reports : innovation in hepatology
Epithelial MLCK deficiency alleviates alcohol-associated liver disease via dendritic-Th17 cell axis.
- 8 May 2026
- JHEP reports : innovation in hepatology
Targeting a tolerogenic HLA-G genotype to tackle immune evasion and adaptive resistance in HBV-driven HCC.
- 8 May 2026
- JHEP reports : innovation in hepatology